3,14-Diacetyloxymorphone
A semi-synthetic opioid analgesic
| 3,14-Diacetyloxymorphone | |
|---|---|
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
3,14-Diacetyloxymorphone is a semi-synthetic opioid analgesic derived from oxymorphone. It is chemically related to other opioids such as morphine and heroin.
Chemical Structure
3,14-Diacetyloxymorphone is an acetylated derivative of oxymorphone, with acetyl groups at the 3 and 14 positions of the morphinan skeleton. This modification increases its lipophilicity, potentially enhancing its ability to cross the blood-brain barrier.
Pharmacology
As an opioid, 3,14-Diacetyloxymorphone acts primarily on the mu-opioid receptor, producing effects such as analgesia, euphoria, and respiratory depression. Its potency and efficacy are influenced by its chemical structure, which affects its binding affinity and intrinsic activity at opioid receptors.
Synthesis
The synthesis of 3,14-Diacetyloxymorphone involves the acetylation of oxymorphone. This process typically uses acetic anhydride as the acetylating agent in the presence of a catalyst or under specific conditions to ensure selective acetylation at the desired positions.
Medical Use
While 3,14-Diacetyloxymorphone itself is not commonly used in clinical practice, its parent compound, oxymorphone, is used for the management of moderate to severe pain. The acetylated derivative may have been studied for its pharmacokinetic properties or potential as a prodrug.
Legal Status
Due to its structural similarity to other controlled opioids, 3,14-Diacetyloxymorphone is likely to be regulated under similar legal frameworks. It may be classified as a controlled substance in many jurisdictions, subject to restrictions on its manufacture, distribution, and use.
Related pages
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD